Viability tests showed that in line with HCC cellular heterogeneity and the basal expression of PD-L1, the growth of the HCC cells was altered in the presence of Jurkat cells, anti-PD-L1, and 5-AZA. The gene discussed is CD274; the disease is hepatocellular carcinoma.